Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParity Regulatory News (PTY)

Share Price Information for Parity (PTY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.875
Bid: 0.85
Ask: 0.90
Change: 0.00 (0.00%)
Spread: 0.05 (5.882%)
Open: 0.875
High: 0.875
Low: 0.875
Prev. Close: 0.875
PTY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding - Options Grant

25 Nov 2020 07:00

RNS Number : 3734G
Parity Group PLC
25 November 2020
 

25 November 2020

 

Parity Group plc ("Parity" or the "Company")

Grant of Options to Directors/PDMRs

 

The Board of Parity (AIM:PTY), the technology focussed professional services business, announces that it has awarded Michael Johns, Chief Financial Officer, options over 2,000,000 ordinary shares of 2 pence each in the Company ("the Share Options"). The Share Options were granted on 24 November 2020 and represent approximately 1.9% of the Company's current issued share capital.

 

The Share Options each have an exercise price, calculated in accordance with the rules of the Parity Group 2019 EMI Options Plan, of 7.88 pence, being the closing mid-market price per ordinary share on 23 November 2020.

 

The Share Options will vest after 3 years and are subject to the following performance conditions:

 

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 12.0 pence for a period of at least five consecutive trading days at any time during the vesting period;

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 15.0 pence for a period of at least five consecutive trading days at any time during the vesting period; and

· One third of each individual grant of Share Options will be exercisable if the share price achieves or exceeds 18.0 pence for a period of at least five consecutive trading days at any time during the vesting period.

 

 

 

Contacts:

Parity Group plc www.parity.net

Matthew Bayfield, CEO 0208 171 1729

 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge 0207 220 1666

 

Donhead Consultants

David Beck +44 7836 293383

 

 

 

 

 

 

The notifications below, made in accordance with the EU Market Abuse Regulation, provide further details in relation to the grant of the Share Options to the PDMRs:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Michael Johns

2

 

Reason for the notification

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Parity Group plc

b)

 

LEI

213800YEHAYBJ63OHB38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2p each

 

GB00B1235860

b)

 

Nature of the transaction

 

Grant of options to subscribe for new ordinary shares under the Company's 2019 EMI Option Plan.

c)

 

Price(s) and volume(s)

 

Option Price(s)

 

Volume(s)

7.88p

2,000,000

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

2,000,000

 

£157,600.00

 

e)

 

Date of the transaction

24 November 2020

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGQWGUPUGAC
Date   Source Headline
15th Apr 20247:00 amRNSHolding(s) in Company
5th Apr 20243:41 pmRNSHolding(s) in Company
13th Mar 20245:59 pmRNSHolding(s) in Company
13th Mar 20245:00 pmRNSReceipt of Final Consideration
1st Feb 20243:10 pmRNSHolding(s) in Company
25th Jan 20247:00 amRNSHolding(s) in Company
19th Dec 202310:59 amRNSHolding(s) in Company
8th Dec 20232:31 pmRNSCompletion of Disposal, Change of Name & Website
7th Dec 20235:07 pmRNSResult of General Meeting
21st Nov 20232:43 pmRNSProposed disposal of PPL and notice of GM
29th Sep 20237:00 amRNSInterim Results
4th Aug 20237:00 amRNSTrading Statement
15th Jun 20234:05 pmRNSResult of AGM
15th Jun 20237:00 amRNSAGM Statement
22nd May 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
16th May 20237:00 amRNSFinal Results
26th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSTrading Update
30th Dec 20227:00 amRNSSale and Licence of Trademark
29th Sep 20227:00 amRNSInterim Results
25th Jul 20227:00 amRNSTrading Update
20th Jun 20222:20 pmRNSHolding(s) in Company
8th Jun 20221:24 pmRNSResult of AGM
8th Jun 20227:00 amRNSAGM Statement
16th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
12th May 20227:00 amRNSChange of Adviser
9th May 20227:00 amRNSDirector Dealing
27th Apr 20227:00 amRNSFinal Results
20th Jan 20227:00 amRNSTrading Update
4th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSContract award
4th Oct 20217:00 amRNSGrant of Warrants and Options to Directors/PDMRs
22nd Sep 20218:41 amRNSInvestor Presentation
22nd Sep 20217:00 amRNSInterim Results
26th Aug 202110:40 amRNSTrading Update
24th Jun 202112:00 pmRNSIssue of Equity, Option Grant & Director Shares
10th Jun 202112:15 pmRNSResult of AGM
9th Jun 20212:40 pmRNSDirectorate Change
18th May 202111:18 amRNSNotice of AGM and Posting of Accounts
4th May 20219:50 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSDirectorate Change
21st Apr 20217:00 amRNSFinal Results
12th Apr 20217:00 amRNSChange of Adviser
1st Mar 20217:00 amRNSNew contract wins and Notice of Results
1st Feb 20217:00 amRNSContract win
28th Jan 20217:00 amRNSTrading Statement
25th Nov 20207:00 amRNSDirector/PDMR Shareholding - Options Grant
22nd Sep 20207:00 amRNSInterim results
3rd Sep 20207:00 amRNSFramework Agreement and Notice of Interim Results
27th Aug 202011:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.